Medical Oncologist
Your treatment plan
Does having chemotherapy first reduce your survival chances?
No. Large trials gave some women chemotherapy before surgery and others the same chemotherapy after, then followed them for years, and survival was the same. The cancer is under treatment from the first cycle, not left alone. This page explains what the evidence shows, what the order genuinely changes, and what matters while you wait.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
The short answer
Does having chemotherapy first shorten my life?
No. This has been tested directly in large trials that gave some women chemotherapy before surgery and others the same chemotherapy after, then followed them for many years. Survival was the same in both groups. It is one of the more settled questions in breast cancer.
Why the question feels so urgent
Because leaving a known cancer in the body for months runs against every instinct. Families picture it growing while nothing is done. The picture is wrong: the cancer is under treatment from the first cycle, and systemic treatment reaches cells that surgery never could.
What the trials actually showed
The same survival, and a higher chance of keeping the breast in the group treated first. There was a small increase in cancer returning in the breast itself, seen mainly in older studies where surgery was scaled back too far after a good response. Modern practice accounts for that.
The part that is genuinely better
Only this order tells you how your cancer responded. That result now determines who is offered additional treatment after surgery, and those treatments have improved outcomes for people whose cancer did not disappear. Having surgery first means the question is never asked.
If your oncologist recommends this order, ask what they expect to learn from the response. It is a concrete answer.Words you will meet
The vocabulary, in plain language
- Neoadjuvant
- Treatment given before surgery. Adjuvant means the same treatment given after.
- Overall survival
- How long people live, from any cause. This is the measure that matters most and the one that was identical in the trials.
- Local recurrence
- Cancer returning in the same breast or chest wall. Different from cancer returning elsewhere in the body.
- Complete response
- No invasive cancer found in the removed tissue. Associated with better outcomes, particularly in triple negative and HER2 positive disease.
- Residual disease
- Cancer still present at surgery. It is the group for whom extra treatment afterwards is now offered.
- Downstaging
- The cancer shrinking enough to allow a smaller operation than was first planned.
Not sure whether this applies to you?
Ask an oncologistBeing a good advocate
What genuinely matters while you wait
The order is safe. These are the things that actually affect how well it goes.
That a marker clip was placed
If the cancer shrinks away completely, the clip is how the surgeon finds the site. Without one, more tissue than necessary may have to be removed. Ask directly whether yours is in.
That the response is being checked
Examination before each cycle, and usually a scan partway through. This is what catches a cancer that is not responding while there is still time to change the plan.
Ask what would happen if it stopped responding.That the course is completed
Missed or heavily delayed cycles reduce the benefit. If side effects are making you consider stopping, say so early, because doses and supportive medicines can usually be adjusted.
That surgery follows promptly
A gap of a few weeks after the last cycle is normal and planned. A gap that keeps drifting with no explanation is worth chasing.
Ask for in writing
- The planned surgery date
- Who to contact if it slips
- What the response assessment showed
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Side by side
What the order does and does not change
Unchanged by having chemotherapy first
Changed by it
How long people live
The chance of keeping your breast
The drugs used and the number of cycles
Whether you learn how your cancer responded
Whether radiotherapy is needed
Access to extra treatment if cancer remains
Your receptor and HER2 results
How much armpit surgery may be needed
The need for hormone tablets afterwards
How long you wait before the cancer is removed
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What people are told by relatives and neighbours
Every month it stays inside is a month lost.
The cancer is being treated throughout, not watched. Chemotherapy acts on cancer cells wherever they are, including any that have already left the breast, which is something surgery cannot do. Trials followed women for years and found no survival difference.
A good hospital would operate immediately.
Choosing the order deliberately is a mark of a team working to current practice, usually after discussing your case at a tumour board. Operating on everyone immediately would be simpler and would serve some women worse.
Chemotherapy will weaken her too much for surgery.
Surgery is scheduled once blood counts have recovered, usually a few weeks after the last cycle, and your surgeon and anaesthetist check you are fit before proceeding. Wound healing is monitored more closely, but the operation itself goes ahead as planned.
We should get a second opinion because this sounds wrong.
Ask for one if you want it, and no reasonable oncologist will object. Take your full reports. What you are likely to hear is the same recommendation explained differently, and hearing it twice helps many families settle.
Where the answer comes from
How this question was actually settled
-
The question was asked properly
Rather than comparing women who happened to be treated differently, trials allocated the order at random. That matters, because doctors naturally send the more worrying cancers for treatment first, which would make any simple comparison look bad.
-
Both groups got the same drugs
The same regimens, the same number of cycles, the same surgery and the same radiotherapy afterwards. The only deliberate difference was whether the chemotherapy came before or after the operation.
-
Women were followed for many years
Long enough for differences in survival to appear if there were any. Short follow-up is the usual weakness in cancer research, and it is not the weakness here.
-
Survival came out the same
No difference in how long women lived, in either direction. More women in the chemotherapy-first group were able to keep their breast.
-
The findings were pooled and rechecked
Results from the separate trials were later combined and analysed together, which confirmed the same conclusion and picked up the small rise in cancer returning within the breast that current practice now guards against.
Questions we are asked
Common questions about the order of treatment
Is the evidence really settled on this?
As settled as these questions get. Multiple randomised trials compared the two orders and followed women for many years, and overall survival was the same. It is one of the reasons oncologists recommend this approach without hesitation for the subtypes where it applies.
Why does my relative's doctor disagree?
Often because their cancer was a different subtype. Chemotherapy first suits triple negative and HER2 positive cancers particularly well, and suits small hormone sensitive cancers poorly. Two different recommendations can both be correct for two different people.
Does the small rise in local recurrence worry you?
It is worth knowing about and it is manageable. It was seen mainly in older studies where surgery was scaled back too far after a good response. Current practice uses the marker clip and checks margins carefully to avoid exactly that.
What if I simply cannot bear waiting?
Say so plainly to your oncologist rather than agreeing and then suffering. For some cancers surgery first costs very little. For others it closes off a treatment option. Understanding what you would be trading makes the decision yours rather than imposed.
Does a complete response mean I am free of cancer?
It means no invasive cancer was found in the tissue removed, which is genuinely encouraging and linked to better outcomes. It is not a promise that no cell survived anywhere, which is why radiotherapy and hormone tablets continue as planned.
Will I need more cycles after surgery too?
Sometimes, depending on the response and your subtype. Where cancer remains, additional treatment after surgery is often offered specifically because of that result. Your oncologist will explain what is being added and why once the report is back.
Can I change my mind partway through?
You can, and it is worth discussing rather than simply stopping. Sometimes surgery is brought forward for good reasons, including poor response or difficult side effects. Talk to your oncologist before making the decision alone.
Should the whole plan be discussed at a tumour board?
It should, and you are entitled to ask whether it was. A recommendation about the order of treatment is exactly the kind of decision that benefits from surgical, medical and radiation oncologists considering it together rather than one doctor alone.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- Cancer Research UK — Chemotherapy before surgery for breast cancer
- National Cancer Institute — Neoadjuvant therapy for breast cancer
- Breast Cancer Now — Chemotherapy before surgery
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.